UMIN ID: UMIN000002617
Registered date:31/03/2010
Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Small-Cell Lung Cancer |
Date of first enrollment | 2008/02/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | amrubicin Re-challange of platinum-doublet |
Outcome(s)
Primary Outcome | Response rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Pre-treated with amrubicin With severe co-morbidities With symptomatic brain metastasis |
Related Information
Primary Sponsor | Tohoku University Hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Tohoku University Hospital |
Secondary ID(s) |
Contact
public contact | |
Name | Akira Inoue |
Address | 1-1, Seiryocho, Aobaku, Sendai |
Telephone | +81-22-717-8539 |
akinoue@idac.tohoku.ac.jp | |
Affiliation | Tohoku University Hospital Department of Respiratory Medicine |
scientific contact | |
Name | Akira Inoue |
Address | 1-1, Seiryomachi, Aobaku, Sendai |
Telephone | +81-22-717-8539 |
akinoue@idac.tohoku.ac.jp | |
Affiliation | Tohoku University Hospital Department of Respiratory Medicine |